David F. McDermott, MD, Eric Jonasch, MD, and Sumanta Kumar Pal, MD, discuss renal cell carcinoma in this CME activity titled "Defining the Role of Novel Multikinase Inhibitors and Immunotherapies in Advanced RCC: Key Advances and Current Impact on Patient Care." For the full presentation, downloadable Practice Aids, monograph, complete CME information, and to apply for credit, please visit us at http://bit.ly/2uznK1A. CME credit will be available until July 12, 2018.